TheraDiag SA (ALTER):企業の財務・戦略的SWOT分析

◆英語タイトル:TheraDiag SA (ALTER) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH140366FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. Theradiag provides tests using techniques and automatic devices and solutions for high-speed diagnostics. The company also offers multi-parametric monitoring system for treatment of autoimmune diseases by anti-TNF. It provides in-vitro diagnostic products in the fields of auto-immunity, allergies, infectious diseases and, more recently, oncology and molecular biology. The company serves autoimmune disease diagnostic markets. Theradiag is headquartered in Paris, France

TheraDiag SA Key Recent Developments

Mar 22,2021: Theradiag announces its 2020 full-year results
Dec 14,2020: Clinical study that meets French National Authority for health requirements highlights the quality of the tests marketed by Theradiag
Sep 24,2020: Theradiag opens a new site in Tours
Sep 22,2020: 21/09/2020: French company Theradiag launches an antigen test in France to detect COVID-19 in less than 15 minutes

This comprehensive SWOT profile of TheraDiag SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of TheraDiag SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

TheraDiag SA – Key Information
TheraDiag SA – Overview
TheraDiag SA – Key Employees
TheraDiag SA – Key Employee Biographies
TheraDiag SA – Key Operational Heads
TheraDiag SA – Major Products and Services
TheraDiag SA – History
TheraDiag SA – Company Statement
TheraDiag SA – Locations And Subsidiaries
TheraDiag SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

TheraDiag SA – Business Description
TheraDiag SA – Corporate Strategy
TheraDiag SA – SWOT Analysis
SWOT Analysis – Overview
TheraDiag SA – Strengths
TheraDiag SA – Weaknesses
TheraDiag SA – Opportunities
TheraDiag SA – Threats
TheraDiag SA – Key Competitors

Section 3 – Company Financial Performance Charts

TheraDiag SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

TheraDiag SA, Key Information
TheraDiag SA, Key Ratios
TheraDiag SA, Share Data
TheraDiag SA, Major Products and Services
TheraDiag SA, History
TheraDiag SA, Key Employees
TheraDiag SA, Key Employee Biographies
TheraDiag SA, Key Operational Heads
TheraDiag SA, Other Locations
TheraDiag SA, Subsidiaries
TheraDiag SA, Key Competitors
TheraDiag SA, SWOT Analysis
TheraDiag SA, Ratios based on current share price
TheraDiag SA, Annual Ratios
TheraDiag SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[TheraDiag SA (ALTER):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SPX Corp (SPXC):企業の財務・戦略的SWOT分析
    SPX Corp (SPXC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Supreme Pharmaceuticals Inc (SL)-製薬・医療分野:企業M&A・提携分析
    Summary Supreme Pharmaceuticals Inc (Supreme Pharmaceuticals), formerly Supreme Resources Ltd is a medial products production and distributing company. The company's products include medical marijuana, sun grown marijuana and others. It offers services such as production, exploration, trading, culti …
  • Laboratoire Aguettant SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoire Aguettant (Aguettant) is a pharmaceutical company that offers development, manufacturing and commercialisation of essential hospital medicines. The company offers products under various categories such as specialist sectors and delivery systems. Its speciality sector offers emerg …
  • Noranda Income Fund (NIF.UN):企業の財務・戦略的SWOT分析
    Noranda Income Fund (NIF.UN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PT Sinar Mas Agro Resources and Technology Tbk (SMAR):企業の財務・戦略的SWOT分析
    PT Sinar Mas Agro Resources and Technology Tbk (SMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • Belize Electricity Ltd:企業の戦略的SWOT分析
    Belize Electricity Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Zhejiang Hisoar Pharmaceutical Co Ltd (002099):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Hisoar Pharmaceutical Co Ltd (Hisoar) is a pharmaceutical company that offers specialty raw materials, preparations, fine chemicals, dyes and intermediates. The company offers raw drugs such as antibody, anti-virus, sugar-reducing, cardiovascular and worm-driven drugs. It produces f …
  • CynergisTek, Inc. (CTEK):企業の戦略的SWOT分析
    CynergisTek, Inc. (CTEK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Kyocera Corporation:企業の戦略・SWOT・財務情報
    Kyocera Corporation - Strategy, SWOT and Corporate Finance Report Summary Kyocera Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • OpGen Inc (OPGN):製薬・医療:M&Aディール及び事業提携情報
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • Hoteli Maestral d.d.:企業の戦略・SWOT・財務情報
    Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report Summary Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Karyopharm Therapeutics Inc (KPTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Karyopharm Therapeutics Inc (Karyopharm Therapeutics) is a clinical-stage pharmaceutical company that discovers and develops novel drugs for the treatment of cancer and other diseases. The company develops small molecule selective inhibitor of nuclear export compounds that inhibit the nuclea …
  • Oxford BioTherapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford BioTherapeutics Ltd (OBT) is a clinical stage oncology company that develops antibody drug conjugates for the treatment of variety of cancers. The company’s product pipelines currently includes T-cell based IO therapies including check point modulators; NK cell based IO therapies such …
  • Hydrodec Group Plc (HYR):石油・ガス:M&Aディール及び事業提携情報
    Summary Hydrodec Group Plc (Hydrodec) is an oil and gas company that offers oil refining services. The company produces, markets and distributes transformer oil and naphthenic base oil. It undertakes collection, transportation and processing of used non-PCB and PCB-contaminated naphthenic-based tran …
  • Salzgitter AG:企業の戦略・SWOT・財務情報
    Salzgitter AG - Strategy, SWOT and Corporate Finance Report Summary Salzgitter AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The J.M. Smucker Co:戦略・SWOT・企業財務分析
    The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report Summary The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Australian Postal Corporation:企業の戦略・SWOT・財務情報
    Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report Summary Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ContourGlobal plc (GLO):企業の財務・戦略的SWOT分析
    ContourGlobal plc (GLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Zehnder Group AG (ZEHN):企業の財務・戦略的SWOT分析
    Zehnder Group AG (ZEHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Ping An Insurance (Group) Company of China, Ltd.:企業のM&A・事業提携・投資動向
    Ping An Insurance (Group) Company of China, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ping An Insurance (Group) Company of China, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descri …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆